BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8638257)

  • 1. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution, teratogenicity, and embryonic delivered dose of retinoid Ro 23-9223.
    Willhite CC; Lovey A; Eckhoff C
    Toxicol Appl Pharmacol; 2000 Apr; 164(2):171-5. PubMed ID: 10764630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-selective retinoid agonists and teratogenic activity.
    Willhite CC; Dawson MI; Reichert U
    Drug Metab Rev; 1996; 28(1-2):105-19. PubMed ID: 8744592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonic delivered dose of isotretinoin (13-cis-retinoic acid) and its metabolites in hamsters.
    Eckhoff C; Willhite CC
    Toxicol Appl Pharmacol; 1997 Sep; 146(1):79-87. PubMed ID: 9299599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pattern of retinoid-induced teratogenic effects: possible relationship with relative selectivity for nuclear retinoid receptors RAR alpha, RAR beta, and RAR gamma.
    Elmazar MM; Reichert U; Shroot B; Nau H
    Teratology; 1996 Mar; 53(3):158-67. PubMed ID: 8761883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple factors contribute to the toxicity of the aromatic retinoid, TTNPB (Ro 13-7410): binding affinities and disposition.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):319-27. PubMed ID: 9070355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative teratogenicity of three retinoids: the arotinoids Ro 13-7410, Ro 13-6298 and Ro 15-1570.
    Kistler A; Galli B; Howard WB
    Arch Toxicol; 1990; 64(1):43-8. PubMed ID: 2306193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of RAR-beta 2 gene expression in embryos and RAR-beta 2 transactivation by the synthetic retinoid Ro 13-6307 correlates with its high teratogenic potency.
    Soprano DR; Tairis N; Gyda M; Harnish DC; Jiang H; Soprano KJ; Kochhar DM
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):159-63. PubMed ID: 8397452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective agonists of retinoic acid receptors: comparative toxicokinetics and embryonic exposure.
    Arafa HM; Elmazar MM; Hamada FM; Reichert U; Shroot B; Nau H
    Arch Toxicol; 2000 Jan; 73(10-11):547-56. PubMed ID: 10663386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental transfer and developmental effects of 9-cis retinoic acid in mice.
    Kochhar DM; Jiang H; Penner JD; Heyman RA
    Teratology; 1995 Apr; 51(4):257-65. PubMed ID: 7570368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of high dysmorphogenic activity of Ro 13-6307, a tetramethylated tetralin analog of retinoic acid.
    Kochhar DM; Penner JD
    Teratology; 1992 Jun; 45(6):637-45. PubMed ID: 1412056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple factors contribute to the toxicity of the aromatic retinoid TTNPB (Ro 13-7410): interactions with the retinoic acid receptors.
    Pignatello MA; Kauffman FC; Levin AA
    Toxicol Appl Pharmacol; 1999 Sep; 159(2):109-16. PubMed ID: 10495774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
    Tembe EA; Honeywell R; Buss NE; Renwick AG
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-toxicity relationships of the tetramethylated tetralin and indane analogs of retinoic acid.
    Howard WB; Willhite CC; Sharma RP
    Teratology; 1987 Dec; 36(3):303-11. PubMed ID: 3424219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-affinity relationships of retinoids with embryonic cellular retinoic acid-binding protein.
    Willhite CC; Jurek A; Sharma RP; Dawson MI
    Toxicol Appl Pharmacol; 1992 Jan; 112(1):144-53. PubMed ID: 1310166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single versus multiple dose administration of all-trans-retinoic acid during organogenesis: differential metabolism and transplacental kinetics in rat and rabbit.
    Collins MD; Tzimas G; Bürgin H; Hummler H; Nau H
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):9-18. PubMed ID: 7839374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of arotinoids upon murine embryonal carcinoma cells.
    Sherman MI; Paternoster ML; Taketo M
    Cancer Res; 1983 Sep; 43(9):4283-90. PubMed ID: 6307509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoic acid-binding protein in the chick limb bud: identification at developmental stages and binding affinities of various retinoids.
    Maden M; Summerbell D
    J Embryol Exp Morphol; 1986 Sep; 97():239-50. PubMed ID: 3025329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.